The advent of high-density recording technologies, such as Neuropixels and large-scale calcium imaging, has provided an unprecedented look into the ...

Artificial intelligence is no longer confined to data crunching and automation; it's making profound inroads into the creative industries. Generative models like generative adversarial networks (GANs) ...

This Collection supports and amplifies research related to SDG 9 - Industry, Innovation & Infrastructure. Generative modeling for chemistry discovery is an emerging field at the intersection of ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I will identify and discuss an important AI ...

Banks are deploying generative AI for a growing number of tasks from the mundane to the miraculous: writing emails, assessing credit risk, predicting trade fails.

Researchers have found that training successive generations of generative artificial intelligence models on synthetic data gives rise to self-consuming feedback loops. Generative artificial ...

Google has begun rolling out private access to its Veo and Imagen 3 generative AI models. Starting today, customers of the company’s Vertex AI Google Cloud package can begin using Veo to generate ...

Researchers have developed a systematic review that charts the evolution of artificial intelligence in generative design for steel modular structures, particularly steel box modular buildings, ...

Bio (NASDAQ:IBIO) is seeking to narrow what it views as a growing “trust gap” between the promise of generative AI in drug discovery and the high cost and long timelines of bringing a drug to market, ...

According to MarketsandMarkets™, the Generative AI Server Market is expected to reach USD 448.60 billion by 2030 from USD 103.92 billion in 2025, registering a CAGR of 34.0% during the forecast period ...

Inhaled KB707, a novel HSV-based immunotherapy, as a monotherapy in patients with advanced solid tumor malignancies affecting the lungs: Efficacy and safety results from a phase 1/2 study. Completed ...